België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kela pharma sa-nv - sulfacetamidenatrium 100 mg/ml - oplossing voor cutaan gebruik - 10 % - sulfacetamidenatrium 100 mg/ml - sulfacetamide

Europese Unie - Nederlands - EMA (European Medicines Agency)

mylan ireland limited - fingolimod hydrochloride - multiple sclerose, relapsing-remitting - immunosuppressiva - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 en 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium - geattenueerd boviene coronavirus min. 10exp5 ccid50 - max. 10exp7,5 ccid50; geïnactiveerd escherichia coli, stam nadc 1471 0101, fimbriale aanhechtingsfactoren f5 induisant = 4.5 log 2 titre d’anticorps; geattenueerd, boviene rotavirus 10000000 ccid50 - lyofilisaat en oplosmiddel voor oplossing voor injectie - geïnactiveerd escherichia coli, stam nadc 1471 0101, fimbriale aanhechtingsfactoren f5; boviene coronavirus; boviene rotavirus - live bovine rotavirus + live bovine coronavirus + inactivated escherichia - rund